Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024
Project: GvHDCure
Updated at: 27-04-2024